Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain-Reference-Cited by-同舟云学术

Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain

Published:2016-12 Issue:4 Volume:86 Page:470-471
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

García-Fernández Sergio,Morosini María-Isabel,Cobo Marta,Foruny José Ramón,López-Sanromán Antonio,Cobo Javier,Romero José,Cantón Rafael,del Campo Rosa^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance;Baquero;Antimicrob Agents Chemother,2011

2. Effects of selective digestive decontamination (SDD) on the gut resistome;Buelow;J Antimicrob Chemother,2014

3. Distinct but spatially overlapping intestinal niches for vancomycin-resistant Enterococcus faecium and carbapenem resistant Klebsiella pneumoniae;Caballero;PLoS Pathog,2015

4. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization;Crum-Cianflone;J Clin Microbiol,2015

5. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping;Indra;J Med Microbiol,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boosting Fitness Costs Associated with Antibiotic Resistance in the Gut: On the Way to Biorestoration of Susceptible Populations;Biomolecules;2024-01-08

2. The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases;Gut Microbes;2022-03-01

3. Fecal microbiota transfer: Basic and clinical aspects, current applications, and future perspectives;Human-Gut Microbiome;2022

4. Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae;European Journal of Microbiology and Immunology;2020-10-14

5. Actualización sobre infección por Clostridium difficile en el paciente mayor;Revista Española de Geriatría y Gerontología;2020-07